Method of Determining Risk of Autism Spectrum Disorder
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 15, 2013
app pub date -
Jan 25, 2013
filing date -
Jan 25, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method of assessing risk in a human subject of ASD is provided comprising the step of identifying in a nucleic acid-containing sample obtained from the human subject copy number variations associated with SHANK1. Determination of copy number variations associated with SHANK1 is indicative of a risk of ASD in the human subject.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully